Helmholtz Zentrum Munchen

The Helmholtz Zentrum München is a member of the Helmholtz Association of German Research Centres and is responsible for studying environmental health issues

AI can now compare individual patient cells with a reference atlas of cells of healthy individuals for more personalized medicine

Self-learning algorithms require just seconds to interpret whole-body scans of mice improving analysis considerably

Is there a hormonal off switch for hunger that could help tackle obesity?

The world’s smallest ultrasound detector

New gene correction therapy for Duchenne muscular dystrophy

Melanin could be a new diagnosis and treatment tool for tumors

The dark skin pigment melanin protects us from the sun’s damaging rays by absorbing light energy and converting it to heat. This could make it a very effective tool in tumor diagnosis and treatment, as demonstrated by a team from the Technical University of Munich (TUM) and Helmholtz Zentrum München. The scientists managed to create

Melanin could be a new diagnosis and treatment tool for tumors

New microscope can track natural behavior while simultaneously imaging neuronal activity in the brain

A team of scientists from the Helmholtz Zentrum München and the Technical University of Munich (TUM) has successfully developed a new type of microscope. The so-called NeuBtracker is an open source microscope that allows to observe neuronal activities of zebrafish without perturbing their behavior. This is opening up completely new perspectives for science, because now

New microscope can track natural behavior while simultaneously imaging neuronal activity in the brain

Bright prospects: Repairing neurons with light

Repairing neurons with light

Bright prospects: Repairing neurons with light

Rapamycin: limited anti-aging effects

Substance makes mice live longer, but hardly slows down the aging process The drug rapamycin is known to increase lifespan in mice. Whether rapamycin slows down aging, however, remains unclear. A team of researchers from the German Center for Neurodegenerative Diseases (DZNE) and the Helmholtz Zentrum München has now found that rapamycin extends lifespan – but its

Rapamycin: limited anti-aging effects

Metabolomics as a Basis for Gender-Specific Drugs

Analyses of the metabolic profile of blood serum have revealed significant differences in metabolites between men and women. In a study to be published on August 11 in the open-access journal PLoS Genetics, scientists at the Helmholtz Zentrum München have concluded that there is a need for gender-specific therapies. Gender-specific therapies may be required for

Metabolomics as a Basis for Gender-Specific Drugs

Fault in Immune Memory Causes Atopic Eczema and Psoriasis

Scientists from the Centre for Allergy and Environment in Munich (ZAUM), the Helmholtz Zentrum München and the Technische Universität München believe they have discovered the causes of atopic eczema and psoriasis. The results of the studies have been published in the New England Journal of Medicine. The findings of a research study conducted by Stefanie

Fault in Immune Memory Causes Atopic Eczema and Psoriasis

The Latest Bing News on:

Helmholtz Zentrum Munchen Research

How Americans View Their Jobs
Fresh data delivered Saturday mornings About a third of workers with jobs that can be done remotely are working from home all the time, according to a new Pew Research Center survey. Most workers are ...
PM Lee receives a first-hand update by Biosyngen on its progress in cell therapy
The city of Guangzhou welcomes Singapore Prime Minister Lee Hsien Loong, the first stop of his week-long visit to China. Accompanying PM Lee in this trip are Foreign Minister Vivian Balakrishnan, ...
Mark Zuckerberg abandons Metaverse for AI
There were just a few subtle signs that the metaverse was no longer Meta’s top goal, hidden in blog postings and earnings calls. A shift in artificial intelligence has already succeeded the king of ...
New targets for CAR-T cell therapy against acute myeloid leukemia through AI-assisted analysis
Two research teams of Professor Dr. Sebastian ... Carsten Marr with Moritz Thomas from the Institute of AI for Health at Helmholtz Munich have now succeeded in discovering such targets.
ITM, Helmholtz Munich and University Hospital Munster Announce Start of Phase I Clinical Trial with Radiotherapeutic ITM-31 for Glioblastoma
Garching/Munich, Munich and Munster, Germany, March 13, 2023 - ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, Helmholtz Munich and the Departments of ...

The Latest Google Headlines on:

Helmholtz Zentrum Munchen Research

[google_news title=”” keyword=”Helmholtz Zentrum Munchen Research” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]

The Latest Bing News on:

Helmholtz Zentrum Munchen Discovery

Cyberangriff auf Helmholtz Zentrum München
Das Helmholtz Zentrum München ist Ziel eines Cyberangriffs geworden. Die Einrichtung mit Sitz in Oberschleißheim (Landkreis München) arbeite an der Wiederherstellung ihrer IT- und ...
Bayern Cyberangriff auf Helmholtz Zentrum München
Oberschleißheim (dpa/lby) - Das Helmholtz Zentrum München ist Ziel eines Cyberangriffs geworden. Die Einrichtung mit Sitz in Oberschleißheim (Landkreis München) arbeite an der ...
Kriminalität: Cyberangriff auf Helmholtz Zentrum München
Das Helmholtz Zentrum München ist Ziel eines Cyberangriffs geworden. Die Einrichtung mit Sitz in Oberschleißheim (Landkreis München) arbeite an der Wiederherstellung ihrer IT- und ...
New targets for CAR-T cell therapy against acute myeloid leukemia through AI-assisted analysis
The physician Sebastian Kobold and the physicist Carsten Marr, together with colleagues from the LMU University Hospital Munich and the Institute of AI for Health at Helmholtz Munich, set out to ...
ITM, Helmholtz Munich and University Hospital Munster Announce Start of Phase I Clinical Trial with Radiotherapeutic ITM-31 for Glioblastoma
The MarketWatch News Department was not involved in the creation of this content. Mar 13, 2023 (GLOBE NEWSWIRE via COMTEX) -- Garching/Munich, Munich and Munster, Germany, March 13, 2023 - ITM ...